Biotech And Pharma Stock News

Novo Eyes Some other Breakout As Weight-Loss Combat Continues

Novo Nordisk ADR Novo Nordisk ADR NVO $2.30 2.39% 94% IBD Inventory Research Inventory with reference to forging flat base with 104 purchase level Relative power line off highs however has trended

November 16, 2023

OpenAI

Biotech Crashes 74% After Surprising Liver Failure Sidelines Two Assessments

Biotech inventory Rapt Therapeutics (RAPT) plummeted to a file low Tuesday after the Meals and Drug Management put two of its medical research on cling. X The corporate is trying out a

February 21, 2024

Business

Why Amgen’s Weight-Loss News Just Sent Lilly To A Record High

Amgen (AMGN) stock went down on Monday, while Eli Lilly (LLY) stock hit a record high after the biotech company announced that its experimental weight-loss drug showed promising results over 150 days.

February 5, 2024

Business

The Ache Continues For Bedraggled Pharma Heavyweight Pfizer

Any other analyst reduce expectancies for Pfizer (PFE) on Friday after the pharma heavyweight issued a disappointing 2024 outlook early this week. Pfizer inventory is now buying and selling at its lowest

December 15, 2023

Business

Moderna Soars On ‘Transformational’ Possible Of Its Most cancers Vaccine

Moderna’s (MRNA) Merck (MRK)-partnered most cancers vaccine lowered the danger of relapse or demise by means of 49% in melanoma sufferers, the corporations mentioned Thursday. The replace fueled giant positive factors for

December 14, 2023

Business

Crispr Whipsaws Decrease After FDA OKs Gene-Modifying Remedy

Stocks of Crispr Therapeutics (CRSP) had a unstable day on Friday after the Meals and Drug Management licensed the corporate’s groundbreaking gene-editing remedy for sickle cellular illness. CRSP inventory rallied forward of

December 9, 2023

Business

The Billion Guess AstraZeneca Is Making In Weight Loss

The $2 Billion Guess AstraZeneca Is Making In Weight Loss

Stocks of AZN inventory popped Thursday after AstraZeneca (AZN) mentioned it might spend as much as $2.01 billion to license an experimental weight-loss drug from Eccogene. X The scoop comes an afternoon

November 10, 2023

Business

Tech Chief Slouches, However Its Past due-Level Pipeline Shines

Buyers in VRTX inventory are carefully staring at Vertex Prescribed drugs’ (VRTX) efforts in ache remedy, analysts stated Tuesday after the biotech corporate reported combined third-quarter effects. X All through the quarter,

November 7, 2023

Business

Biotech And Pharma Stock News

Novo Eyes Some other Breakout As Weight-Loss Combat Continues

Biotech Crashes 74% After Surprising Liver Failure Sidelines Two Assessments

Why Amgen’s Weight-Loss News Just Sent Lilly To A Record High

The Ache Continues For Bedraggled Pharma Heavyweight Pfizer

Moderna Soars On ‘Transformational’ Possible Of Its Most cancers Vaccine

Crispr Whipsaws Decrease After FDA OKs Gene-Modifying Remedy

The $2 Billion Guess AstraZeneca Is Making In Weight Loss

Tech Chief Slouches, However Its Past due-Level Pipeline Shines

Recent Posts

Categories

Suggestions

Biotech And Pharma Stock News

Recent Posts

Categories